<p>Darren Zhu of Synbiosys, LLC in the U.S. aims to produce a low-cost diagnostic platform that can rapidly diagnose leishmaniasis in field conditions. He will engineer a bacterium with cell surface receptors that are activated and amplified by the presence of Leishmania proteases to produce a colorimetric readout. This biologic system could be extended to the rapid diagnosis of other infectious diseases.</p>


Darren Zhu of Synbiosys, LLC in the U.S. aims to produce a low-cost diagnostic platform that can rapidly diagnose leishmaniasis in field conditions. He will engineer a bacterium with cell surface receptors that are activated and amplified by the presence of Leishmania proteases to produce a colorimetric readout. This biologic system could be extended to the rapid diagnosis of other infectious diseases.

Microbial Biosensor for Diagnosing Leishmaniasis

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.